NCT05552365

Brief Summary

This study aims to pilot a world-first intervention, a mental health intervention augmented for children indicated with developmental language disorder (DLD). It serves as a proof-of-concept of how existing observational studies on these topics at the Centre for Research in Child Development (c.f. Tran-Sen; Gibber) can be translated into interventions. Mental health problems here are defined as anxiety type problems of social anxiety, specific phobia, separation anxiety and generalised anxiety. DLD is defined as a marked difficulty in oral language in the absence of biomedical causes (Bishop et al., 2017). This randomised pilot answers three uncertainties in preparation for a future definitive randomised control trial (RCT).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
9

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Dec 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 15, 2022

Completed
8 days until next milestone

First Posted

Study publicly available on registry

September 23, 2022

Completed
3 months until next milestone

Study Start

First participant enrolled

December 16, 2022

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 14, 2024

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 31, 2024

Completed
Last Updated

December 4, 2024

Status Verified

December 1, 2024

Enrollment Period

1.4 years

First QC Date

September 15, 2022

Last Update Submit

December 2, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Anxiety Disorders Interview Schedule (ADIS-IV; Brown et al., 2004)

    The ADIS-IV is a semi-structured interview organised diagnostically to permit differential diagnoses of anxiety disorders. Its yields a severity rating (0 to 8) which is utilised here as the primary outcome

    Administered at post treatment which is a maximum of 4 weeks from final session

Secondary Outcomes (2)

  • Screen for child anxiety related emotional disorders (SCARED; Birmaher et al., 1999)

    Administered at post treatment which is a maximum of 4 weeks from final session

  • Child Anxiety Life Interference Scale (CALIS; Lyneham, et. al., 2013)

    Administered at post treatment which is a maximum of 4 weeks from final session

Other Outcomes (1)

  • Child Outcome and Session Rating Scales (CORS; Duncan et al., 2003)

    At the end of each of the 8-sessions (each session is expected to run for 60 - 90 mins) for the active intervention

Study Arms (2)

Active Intervention

EXPERIMENTAL

8-session cognitive behavioural intervention adapted for children indicated to have developmental language disorder.

Behavioral: Adapted Cognitive Behavioural

Treatment as Usual

OTHER

Participants are re-directed to mental health support services. All participants given a mental health brochure which has contact details of mental health services for children.

Other: Treatment as Usual

Interventions

8-session cognitive behavioural intervention adapted for children indicated to have developmental language disorder. Intervention includes psychoeducative, bodily relaxation, graded exposure, cognitive restructuring and brainstorming. Adaptations include increasing the number of visual supports, use of physical objects to illustrate concepts in addition to language.

Active Intervention

Participants given a mental health brochure with contact information, where they can access services provided by mental health support service providers.

Treatment as Usual

Eligibility Criteria

Age6 Years - 12 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Shows signs of elevated anxiety, fear or stress, as rated on anxiety measures conducted by this study
  • Enrolled in Primary 1 to 6 in a Ministry of Education Primary School
  • Signs of a language difficulty \[Either one of the following\]
  • Existing clinical opinion/report of this when child \>5 years old
  • Score \<10th percentile on language measures conducted by this study

You may not qualify if:

  • Conditions which exclude Developmental Language Disorder (e.g. Autism, Intellectual Disability, Hearing Impairment, other biomedical conditions).
  • Non-anxiety disorder as primary mental health disorder
  • Currently receiving treatment for anxiety disorder (e.g. pharmacotherapy or psychotherapy).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Centre for Research in Child Development, OER, NIE-NTU

Singapore, Singapore

Location

Related Links

MeSH Terms

Conditions

Language Development DisordersLanguage DisordersAnxiety Disorders

Interventions

Therapeutics

Condition Hierarchy (Ancestors)

Communication DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsMental Disorders

Study Officials

  • Shaun KY Goh, PhD

    NTU-NIE

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
The clinical interview (ADIS) will be administered by assessors who will not be told which arm participants are. Participants will be told not to mention intervention arm status to assessors.
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer

Study Record Dates

First Submitted

September 15, 2022

First Posted

September 23, 2022

Study Start

December 16, 2022

Primary Completion

May 14, 2024

Study Completion

October 31, 2024

Last Updated

December 4, 2024

Record last verified: 2024-12

Locations